Lansing Street Advisors Boosts Holdings in UnitedHealth Group Incorporated $UNH

Lansing Street Advisors grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 6.8% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 771 shares of the healthcare conglomerate’s stock after purchasing an additional 49 shares during the quarter. Lansing Street Advisors’ holdings in UnitedHealth Group were worth $241,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of UNH. WoodTrust Financial Corp raised its stake in UnitedHealth Group by 1.2% during the 2nd quarter. WoodTrust Financial Corp now owns 24,417 shares of the healthcare conglomerate’s stock valued at $7,617,000 after buying an additional 298 shares during the last quarter. Traphagen Investment Advisors LLC increased its holdings in UnitedHealth Group by 20.4% in the 2nd quarter. Traphagen Investment Advisors LLC now owns 1,406 shares of the healthcare conglomerate’s stock worth $439,000 after acquiring an additional 238 shares in the last quarter. Winthrop Advisory Group LLC increased its holdings in UnitedHealth Group by 30.3% in the 2nd quarter. Winthrop Advisory Group LLC now owns 1,545 shares of the healthcare conglomerate’s stock worth $482,000 after acquiring an additional 359 shares in the last quarter. Puzo Michael J increased its holdings in UnitedHealth Group by 4.2% in the 2nd quarter. Puzo Michael J now owns 16,653 shares of the healthcare conglomerate’s stock worth $5,195,000 after acquiring an additional 670 shares in the last quarter. Finally, Citizens National Bank Trust Department increased its stake in shares of UnitedHealth Group by 1.8% in the second quarter. Citizens National Bank Trust Department now owns 18,204 shares of the healthcare conglomerate’s stock worth $5,679,000 after purchasing an additional 318 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.4%

UNH opened at $363.95 on Wednesday. The firm has a market cap of $329.62 billion, a P/E ratio of 15.77, a P/E/G ratio of 2.33 and a beta of 0.47. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a 50-day moving average of $311.44 and a 200 day moving average of $352.42.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company’s revenue was up 12.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s payout ratio is presently 38.30%.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on UNH shares. Baird R W lowered UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Royal Bank Of Canada cut their target price on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research report on Wednesday, July 30th. KeyCorp cut their price objective on shares of UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating for the company in a report on Wednesday, July 30th. Piper Sandler cut their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a research note on Wednesday, July 30th. Finally, JPMorgan Chase & Co. cut their target price on shares of UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating for the company in a research note on Wednesday, August 6th. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $365.00.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.